New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
11:22 EDTIDXXIDEXX says FTC grants final approval of consent agreement
IDEXX Laboratories announced that the Commissioners of the U.S. Federal Trade Commission have granted final approval of the consent agreement previously reached between the company and the staff of the FTC Bureau of Competition. The Commission had preliminarily approved the consent agreement in December 2012 and placed the agreement and a proposed draft complaint on public record for comment.The company said, "While we admit no wrongdoing and continue to believe that our distribution practices did not violate the antitrust laws, this marks final resolution of the multi-year FTC investigation."
News For IDXX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
10:01 EDTIDXXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AT&T (T) initiated with a Buy at DA Davidson... Abaxis (ABAX) initiated with an Underperform at Credit Suisse... Aratana Therapeutics (PETX) initiated with an Outperform at Credit Suisse... Care.com (CRCM) initiated with an Equal Weight at Morgan Stanley... GCP Applied Technologies (GCP) initiated with a Buy at Jefferies... Heritage-Crystal Clean (HCCI) initiated with a Buy at Roth Capital... IDEXX (IDXX) initiated with an Outperform at Credit Suisse... Nexvet Biopharma (NVET) initiated with an Outperform at Credit Suisse... PetMed Express (PETS) initiated with an Underperform at Credit Suisse... Phibro Animal Health (PAHC) initiated with an Outperform at Credit Suisse... Pure Storage (PSTG) initiated with a Perform at Oppenheimer... SeaWorld (SEAS) initiated with a Neutral at Janney Capital... Seattle Genetics (SGEN) initiated with an Overweight at Barclays... VCA Inc. (WOOF) initiated with an Outperform at Credit Suisse... Verizon (VZ) initiated with a Neutral at DA Davidson... Zoetis (ZTS) initiated with an Outperform at Credit Suisse.
07:42 EDTIDXXIDEXX initiated with an Outperform at Credit Suisse
Subscribe for More Information
January 29, 2016
07:07 EDTIDXXIDEXX sees FY16 EPS $2.10-$2.17, consensus $2.13
Sees FY16 revenue $1.69B-$1.71B, consensus $1.71B. Sees FY16 free cash flow to be 95%-100% of net income. Sees FY16 CapEx $90M. Sees FY16 operating margin to be 18%-18.5%, or approximately 100 basis points below 2015 adjusted operating margin levels, driven by ForEx impacts including comparisons to benefits from 2015 hedge gains. Sees FY16 effective tax rate of 30%-30.5%.
07:05 EDTIDXXIDEXX reports Q4 normalized organic revenue growth up 11%
Subscribe for More Information
07:05 EDTIDXXIDEXX reports Q4 adjusted EPS 48c, consensus 44c
Reports Q4 revenue $399.69M, consensus $396.99M.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use